Concepts (210)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Diabetes Mellitus, Type 2 | 14 | 2018 | 643 | 0.760 |
Why?
|
| Cultural Diversity | 2 | 2021 | 169 | 0.740 |
Why?
|
| Hawaii | 29 | 2024 | 1929 | 0.740 |
Why?
|
| Body Mass Index | 11 | 2024 | 854 | 0.670 |
Why?
|
| Long QT Syndrome | 2 | 2010 | 13 | 0.620 |
Why?
|
| Insulin Resistance | 1 | 2019 | 184 | 0.590 |
Why?
|
| Glucose Intolerance | 2 | 2007 | 42 | 0.580 |
Why?
|
| Cross-Sectional Studies | 20 | 2024 | 2721 | 0.560 |
Why?
|
| Aging | 3 | 2020 | 664 | 0.550 |
Why?
|
| Electrocardiography | 6 | 2020 | 156 | 0.520 |
Why?
|
| Prevalence | 14 | 2021 | 1455 | 0.490 |
Why?
|
| Middle Aged | 35 | 2020 | 10129 | 0.440 |
Why?
|
| Aged | 25 | 2020 | 6741 | 0.420 |
Why?
|
| Male | 41 | 2024 | 20025 | 0.420 |
Why?
|
| Alzheimer Disease | 1 | 2019 | 905 | 0.410 |
Why?
|
| Adult | 26 | 2024 | 11712 | 0.400 |
Why?
|
| Diabetes Mellitus | 5 | 2009 | 485 | 0.370 |
Why?
|
| Humans | 47 | 2024 | 37093 | 0.350 |
Why?
|
| Rural Health | 2 | 2007 | 53 | 0.350 |
Why?
|
| Atrial Fibrillation | 2 | 2020 | 101 | 0.340 |
Why?
|
| Female | 38 | 2024 | 20969 | 0.330 |
Why?
|
| Obesity | 6 | 2014 | 1067 | 0.330 |
Why?
|
| Sweat Glands | 1 | 2007 | 2 | 0.310 |
Why?
|
| Sympathetic Fibers, Postganglionic | 1 | 2007 | 3 | 0.310 |
Why?
|
| Sweating | 1 | 2007 | 5 | 0.310 |
Why?
|
| Risk Factors | 15 | 2020 | 3562 | 0.300 |
Why?
|
| Death, Sudden, Cardiac | 1 | 2006 | 21 | 0.290 |
Why?
|
| Peptidyl-Dipeptidase A | 1 | 2006 | 31 | 0.290 |
Why?
|
| Acculturation | 2 | 2024 | 188 | 0.270 |
Why?
|
| Mass Screening | 1 | 2010 | 462 | 0.270 |
Why?
|
| Polymorphism, Genetic | 1 | 2006 | 191 | 0.270 |
Why?
|
| Blood Glucose | 4 | 2009 | 353 | 0.240 |
Why?
|
| Aged, 80 and over | 8 | 2020 | 2379 | 0.230 |
Why?
|
| Health Status | 2 | 2024 | 380 | 0.230 |
Why?
|
| Age Factors | 3 | 2019 | 1033 | 0.200 |
Why?
|
| Niacin | 2 | 2013 | 22 | 0.200 |
Why?
|
| Health Status Disparities | 2 | 2020 | 642 | 0.200 |
Why?
|
| Sleep Apnea, Central | 1 | 2020 | 3 | 0.180 |
Why?
|
| Atrial Flutter | 1 | 2020 | 6 | 0.180 |
Why?
|
| Regression Analysis | 5 | 2010 | 455 | 0.180 |
Why?
|
| Autonomic Nervous System | 2 | 2012 | 33 | 0.170 |
Why?
|
| Coronary Disease | 1 | 2020 | 124 | 0.170 |
Why?
|
| Sex Factors | 4 | 2020 | 898 | 0.170 |
Why?
|
| Hypertension | 3 | 2005 | 796 | 0.170 |
Why?
|
| HIV Infections | 4 | 2013 | 2303 | 0.150 |
Why?
|
| Odds Ratio | 4 | 2008 | 534 | 0.150 |
Why?
|
| Feeding Behavior | 4 | 2009 | 454 | 0.150 |
Why?
|
| Follow-Up Studies | 1 | 2019 | 974 | 0.140 |
Why?
|
| Longitudinal Studies | 1 | 2019 | 885 | 0.140 |
Why?
|
| Cohort Studies | 7 | 2018 | 1492 | 0.130 |
Why?
|
| Glucose Tolerance Test | 3 | 2015 | 68 | 0.130 |
Why?
|
| Logistic Models | 4 | 2009 | 923 | 0.130 |
Why?
|
| Body Size | 1 | 2014 | 32 | 0.120 |
Why?
|
| Blood Pressure | 3 | 2011 | 646 | 0.120 |
Why?
|
| Rheumatic Fever | 2 | 2006 | 13 | 0.120 |
Why?
|
| Lupus Erythematosus, Systemic | 2 | 2007 | 155 | 0.110 |
Why?
|
| World Health Organization | 2 | 2010 | 31 | 0.110 |
Why?
|
| Lipoproteins | 1 | 2013 | 64 | 0.110 |
Why?
|
| Genetic Predisposition to Disease | 2 | 2006 | 628 | 0.110 |
Why?
|
| Health Surveys | 4 | 2011 | 373 | 0.110 |
Why?
|
| Colorectal Neoplasms | 1 | 2018 | 441 | 0.110 |
Why?
|
| Comorbidity | 3 | 2018 | 623 | 0.110 |
Why?
|
| Japan | 3 | 2011 | 305 | 0.100 |
Why?
|
| Adolescent | 8 | 2011 | 5363 | 0.100 |
Why?
|
| Philippines | 3 | 2006 | 73 | 0.100 |
Why?
|
| Population Surveillance | 2 | 2010 | 238 | 0.100 |
Why?
|
| Proportional Hazards Models | 4 | 2018 | 441 | 0.100 |
Why?
|
| Autonomic Nervous System Diseases | 1 | 2011 | 12 | 0.100 |
Why?
|
| Anti-Retroviral Agents | 1 | 2012 | 147 | 0.100 |
Why?
|
| Viremia | 1 | 2011 | 42 | 0.100 |
Why?
|
| Population Groups | 1 | 2011 | 56 | 0.100 |
Why?
|
| Anthropometry | 2 | 2012 | 97 | 0.100 |
Why?
|
| Cellulitis | 1 | 2010 | 7 | 0.090 |
Why?
|
| Methicillin Resistance | 1 | 2010 | 11 | 0.090 |
Why?
|
| Staphylococcal Skin Infections | 1 | 2010 | 9 | 0.090 |
Why?
|
| Adiposity | 1 | 2012 | 154 | 0.090 |
Why?
|
| Asia | 2 | 2020 | 75 | 0.090 |
Why?
|
| Community-Acquired Infections | 1 | 2010 | 22 | 0.090 |
Why?
|
| Quality of Life | 2 | 2006 | 481 | 0.090 |
Why?
|
| Life Style | 5 | 2014 | 308 | 0.090 |
Why?
|
| Prejudice | 1 | 2011 | 110 | 0.090 |
Why?
|
| Cholesterol, HDL | 1 | 2010 | 97 | 0.090 |
Why?
|
| Vasodilation | 1 | 2010 | 65 | 0.090 |
Why?
|
| Methicillin-Resistant Staphylococcus aureus | 1 | 2010 | 56 | 0.090 |
Why?
|
| Dietary Fiber | 1 | 2009 | 47 | 0.090 |
Why?
|
| Stress, Physiological | 1 | 2011 | 150 | 0.090 |
Why?
|
| Blue Cross Blue Shield Insurance Plans | 1 | 2009 | 6 | 0.090 |
Why?
|
| Diet | 3 | 2014 | 801 | 0.080 |
Why?
|
| Insurance, Health, Reimbursement | 1 | 2009 | 18 | 0.080 |
Why?
|
| Magnesium | 1 | 2009 | 97 | 0.080 |
Why?
|
| Sex Distribution | 4 | 2014 | 215 | 0.080 |
Why?
|
| Predictive Value of Tests | 1 | 2010 | 400 | 0.080 |
Why?
|
| Attitude to Health | 2 | 2014 | 325 | 0.080 |
Why?
|
| Motor Activity | 1 | 2011 | 418 | 0.080 |
Why?
|
| Depression | 2 | 2006 | 712 | 0.080 |
Why?
|
| Adaptation, Psychological | 1 | 2011 | 385 | 0.080 |
Why?
|
| California | 4 | 2011 | 476 | 0.080 |
Why?
|
| Child, Preschool | 4 | 2024 | 1418 | 0.080 |
Why?
|
| Reflex | 1 | 2007 | 34 | 0.080 |
Why?
|
| Energy Intake | 1 | 2008 | 170 | 0.070 |
Why?
|
| Outpatient Clinics, Hospital | 1 | 2007 | 13 | 0.070 |
Why?
|
| Rheumatology | 1 | 2007 | 16 | 0.070 |
Why?
|
| Mutagenesis, Insertional | 1 | 2006 | 32 | 0.070 |
Why?
|
| Sampling Studies | 1 | 2006 | 61 | 0.070 |
Why?
|
| Health Behavior | 1 | 2011 | 537 | 0.070 |
Why?
|
| Axons | 1 | 2007 | 108 | 0.070 |
Why?
|
| Blood Flow Velocity | 2 | 2003 | 61 | 0.070 |
Why?
|
| Introns | 1 | 2006 | 75 | 0.070 |
Why?
|
| Sequence Deletion | 1 | 2006 | 87 | 0.070 |
Why?
|
| Gene Frequency | 1 | 2006 | 195 | 0.070 |
Why?
|
| Pediatrics | 1 | 2007 | 68 | 0.070 |
Why?
|
| Referral and Consultation | 1 | 2007 | 117 | 0.070 |
Why?
|
| Rural Population | 2 | 2007 | 294 | 0.070 |
Why?
|
| Child | 5 | 2024 | 3131 | 0.070 |
Why?
|
| HIV-Associated Lipodystrophy Syndrome | 1 | 2006 | 31 | 0.070 |
Why?
|
| Cultural Characteristics | 1 | 2006 | 125 | 0.070 |
Why?
|
| HIV | 1 | 2006 | 98 | 0.060 |
Why?
|
| Young Adult | 3 | 2010 | 4268 | 0.060 |
Why?
|
| Polyomavirus | 1 | 2004 | 3 | 0.060 |
Why?
|
| Virology | 1 | 2004 | 7 | 0.060 |
Why?
|
| Stress, Psychological | 1 | 2011 | 583 | 0.060 |
Why?
|
| Hyperglycemia | 1 | 2005 | 55 | 0.060 |
Why?
|
| Pilot Projects | 3 | 2013 | 661 | 0.060 |
Why?
|
| Genotype | 1 | 2006 | 730 | 0.060 |
Why?
|
| HIV-1 | 1 | 2010 | 706 | 0.060 |
Why?
|
| United States | 4 | 2020 | 4223 | 0.060 |
Why?
|
| Incidence | 3 | 2014 | 922 | 0.060 |
Why?
|
| Venous Insufficiency | 1 | 2003 | 1 | 0.060 |
Why?
|
| Leg Ulcer | 1 | 2003 | 8 | 0.060 |
Why?
|
| Leg | 1 | 2003 | 19 | 0.060 |
Why?
|
| Pacific Islands | 1 | 2024 | 119 | 0.060 |
Why?
|
| Smoking | 2 | 2011 | 940 | 0.060 |
Why?
|
| Risk Assessment | 3 | 2014 | 753 | 0.060 |
Why?
|
| DNA, Viral | 1 | 2004 | 304 | 0.060 |
Why?
|
| Healthy People Programs | 1 | 2003 | 23 | 0.050 |
Why?
|
| Poverty | 1 | 2006 | 348 | 0.050 |
Why?
|
| Varicose Veins | 1 | 2002 | 1 | 0.050 |
Why?
|
| Virus Replication | 1 | 2004 | 278 | 0.050 |
Why?
|
| Vascular Diseases | 1 | 2002 | 30 | 0.050 |
Why?
|
| Apolipoproteins B | 1 | 2002 | 18 | 0.050 |
Why?
|
| Catechin | 1 | 2002 | 31 | 0.050 |
Why?
|
| Tea | 1 | 2002 | 45 | 0.050 |
Why?
|
| Delayed-Action Preparations | 2 | 2013 | 60 | 0.050 |
Why?
|
| Mortality | 1 | 2003 | 145 | 0.050 |
Why?
|
| Cardiovascular Diseases | 2 | 2005 | 664 | 0.050 |
Why?
|
| Linear Models | 1 | 2002 | 275 | 0.050 |
Why?
|
| Prospective Studies | 2 | 2018 | 1378 | 0.050 |
Why?
|
| Confidence Intervals | 2 | 2011 | 149 | 0.040 |
Why?
|
| Cholesterol | 1 | 2020 | 205 | 0.040 |
Why?
|
| Heart Rate | 2 | 2011 | 253 | 0.040 |
Why?
|
| Survival Analysis | 1 | 2018 | 325 | 0.040 |
Why?
|
| Los Angeles | 1 | 2018 | 380 | 0.040 |
Why?
|
| Epidemiologic Methods | 1 | 2015 | 49 | 0.030 |
Why?
|
| Early Diagnosis | 1 | 2015 | 64 | 0.030 |
Why?
|
| Ideal Body Weight | 1 | 2014 | 3 | 0.030 |
Why?
|
| Diabetes Complications | 2 | 2006 | 90 | 0.030 |
Why?
|
| Acute Disease | 2 | 2006 | 147 | 0.030 |
Why?
|
| Analysis of Variance | 2 | 2006 | 550 | 0.030 |
Why?
|
| Waist-Hip Ratio | 1 | 2012 | 34 | 0.030 |
Why?
|
| Residence Characteristics | 1 | 2015 | 322 | 0.030 |
Why?
|
| Social Support | 2 | 2006 | 394 | 0.030 |
Why?
|
| Waist Circumference | 1 | 2012 | 89 | 0.030 |
Why?
|
| Infant | 2 | 2007 | 1046 | 0.020 |
Why?
|
| Retrospective Studies | 2 | 2010 | 2026 | 0.020 |
Why?
|
| Socioeconomic Factors | 2 | 2006 | 1067 | 0.020 |
Why?
|
| Hydrocortisone | 1 | 2011 | 78 | 0.020 |
Why?
|
| Brachial Artery | 1 | 2010 | 28 | 0.020 |
Why?
|
| CD4 Lymphocyte Count | 1 | 2010 | 189 | 0.020 |
Why?
|
| Chronic Disease | 2 | 2003 | 484 | 0.020 |
Why?
|
| Perception | 1 | 2011 | 195 | 0.020 |
Why?
|
| Diet Surveys | 1 | 2009 | 101 | 0.020 |
Why?
|
| Treatment Outcome | 1 | 2013 | 1369 | 0.020 |
Why?
|
| Antiretroviral Therapy, Highly Active | 1 | 2010 | 221 | 0.020 |
Why?
|
| Polynesia | 1 | 2008 | 7 | 0.020 |
Why?
|
| Factor Analysis, Statistical | 1 | 2008 | 146 | 0.020 |
Why?
|
| Sex Characteristics | 1 | 2009 | 230 | 0.020 |
Why?
|
| Social Class | 1 | 2009 | 247 | 0.020 |
Why?
|
| Educational Status | 1 | 2009 | 313 | 0.020 |
Why?
|
| Hospitals, Rural | 1 | 2007 | 21 | 0.020 |
Why?
|
| Hospitals, Urban | 1 | 2007 | 39 | 0.020 |
Why?
|
| Urban Health | 1 | 2007 | 95 | 0.020 |
Why?
|
| Multivariate Analysis | 1 | 2008 | 583 | 0.020 |
Why?
|
| Tilt-Table Test | 1 | 2006 | 4 | 0.020 |
Why?
|
| Respiration | 1 | 2006 | 58 | 0.020 |
Why?
|
| Chi-Square Distribution | 1 | 2006 | 225 | 0.020 |
Why?
|
| Exercise | 1 | 2011 | 613 | 0.020 |
Why?
|
| Deoxyribonucleases, Type II Site-Specific | 1 | 2004 | 7 | 0.020 |
Why?
|
| Electrophoresis, Agar Gel | 1 | 2004 | 28 | 0.020 |
Why?
|
| Tomography, X-Ray Computed | 1 | 2006 | 214 | 0.020 |
Why?
|
| Veins | 1 | 2003 | 7 | 0.010 |
Why?
|
| Ultrasonography | 1 | 2003 | 112 | 0.010 |
Why?
|
| Body Image | 1 | 2004 | 84 | 0.010 |
Why?
|
| Varicose Ulcer | 1 | 2002 | 1 | 0.010 |
Why?
|
| Infant Mortality | 1 | 2003 | 55 | 0.010 |
Why?
|
| Tobacco Use Disorder | 1 | 2006 | 237 | 0.010 |
Why?
|
| Age Distribution | 1 | 2003 | 225 | 0.010 |
Why?
|
| Cholesterol, VLDL | 1 | 2002 | 4 | 0.010 |
Why?
|
| Hydroxycholesterols | 1 | 2002 | 12 | 0.010 |
Why?
|
| Apolipoprotein B-100 | 1 | 2002 | 7 | 0.010 |
Why?
|
| Anticholesteremic Agents | 1 | 2002 | 23 | 0.010 |
Why?
|
| Cysteine Endopeptidases | 1 | 2002 | 59 | 0.010 |
Why?
|
| Multienzyme Complexes | 1 | 2002 | 69 | 0.010 |
Why?
|
| Body Weight | 1 | 2004 | 434 | 0.010 |
Why?
|
| China | 1 | 2002 | 196 | 0.010 |
Why?
|
| Proteasome Endopeptidase Complex | 1 | 2002 | 114 | 0.010 |
Why?
|
| Acquired Immunodeficiency Syndrome | 1 | 2003 | 215 | 0.010 |
Why?
|
| Tumor Cells, Cultured | 1 | 2002 | 502 | 0.010 |
Why?
|
| Lipids | 1 | 2002 | 235 | 0.010 |
Why?
|
| Time Factors | 1 | 2003 | 1742 | 0.010 |
Why?
|
| Neoplasms | 1 | 2003 | 1103 | 0.010 |
Why?
|